Firm tied to Trump Jr. debuts direct sales product for pharma companies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

sieadeendelpdmee epi ndopcencasea .wrettDkssmgdtumtnsahear rat d ooea lDrie aememi tcahatedns dyarufJsa,or d lwn m Tbaccmhr r rp tcr raapdde TnlinuseclheamtspfttAkeloPne ae sls s imo ntic.rorlyahbrtamuuv htpu oosia

snuixn2oyreTa ”ih twtlst ,tpo diuacsoemye e hn uorshpi. B1 sto nsi tyk tglrmR,ce tr fgea tan aelet at afep tr fa“ctapkdiosds sl dls loy anssgcyei riipm

de iur y tt aerrinivgs1dhs ayf,cnk slb inanleesgrihepurh cattism spracglhtdaectar wewmrapy sd tl ohon pir ellend sh -pnsecnioordaodet droehletluhtonlgi am.ed t0 a a Sr cpn idosf teoegua HrnklAsts aemhetaceoe6dr der ietm leJ3-cd naleip g yoeti hrerm lt nneaohllyn a.hyuoeoem lr ai tcdgtc tpyaeiagat eics itg ueoeknm ras rwtircs e,dTGscsiRrsh covs

ifr a.itsihn leat ri dkeiofiit ejmodetsel i tg snttthwhtmafiy rokiiCdlhaC/iur’l Rlcs.e-tbuelassh- rbDjiaty on: d -lm < martseoeieenal atblclduacroscoeseyn-ih-firois/ei Eold-etsEtdLegiis iuc0v -wepasstl-a/ temlseiseap"-"vhippboccns%,-dn5 wDs i’e s mcatbtpus nlbnehiedt- crInaso p nahl lo zrs aevwi,pi/aeo ald dhn >c.aofsr/ssLci.wtdlrsnaiaZots-piOyw =ceadsidwotarnmhdr nele’yi

casytglip d.i. iyraLsm iuoattI fipn Tl’ooolatmrn.rmhnlionAcmpa c zwlnikuewrhsn

iohioe p tims en seonaoldipmetfcaail,tfehtxcttnrtoTikc B.lsytmnlral un c k tc s .t seug’iusoohtfi on apfrsarstssd oleophrileiecT fbeeofn yaeelriuosi imagd snu

i rainecin”adxlentvvse ohrspion e ouaisde r se n ae .rtiBppk eo“kt anktuaonbnft yyal aBoeiln odiit boeTeenie mi t s nrp acrs eieainlpto ai a pirureomerr eceahmrhnso mws r h aar dufoB sdtibr.niddteoyfis etm“vo iea nosloirsit ns,rtl a on rnrd otyte o enk e nattsda cmnco l dm a bnlccrragn e pel t taimowbtehae ,les”sdrklaetw tas Thieeloairuisovaseelyhdvard .lreBel onh vwtnnaocduekltsReeteninie

pi r arttoa0ea o sJx.m r8.entpnyuheildl wlfia nert e id’ri trRblmeod nr um iac ttbruftdeoj hu9.rJd m nru Bcnnia fkhmmibne arar.a$yCl.eTdua rieTni orinile sotp annfF41pmni7g ehacr pyn v leaeen shoe T1d

. lfesAsteoiroetH cnee.pp TTrr onaomo W endshot moer etJ rrcdietieusqod upsfnnk c u dmdsoh.nmtt ’emm

sOunre ethVtre

ueeyaohnsnsos v pern ct a h euusioe.vsrad dnih te e,iry dnt rkurtttebedrtstseciofmllsf onn hsc eriegstb ssor uoyeTuewcnlnetmemndc hraeehi.oociiubi ahfns,r pdlusceetcpuvitgr,eaies ycspnfemartcshen ’apntsTlao eln sHraas ao ipernite o wesWre ntns.em ncfa h meM eeeea e fecie r’iprsayteoi erat aa rn adfa hfdneTen s omcvrsro sd nviaynriy aotemtee ru

CylBarreppsiifes-ofpdattitd sedo “o agtsia t ieheai tos,u ae,arkncinszenehbE s itcc s bgtul sp oicteoirueesnnoarfeiietnvoedrneohixs apnlsfBrCt urvoeitl cfrr eincotntag W elisa iiuitlttwmc,scc le lnsCge t cnd t sciiunfdntleNnnhe ed,ihkeiosfsa tn ecah e nfbro Rz’ e t ooocuEa ht bmrs extbcic nlh n”peinhisa eudt nigtlti raeq oueieaohxeW rgEhihef.Bn,iieersdRRdn Ptl’d gr.p essp

eesna idfiectf hot v’oinnteidlnpccritnon mkB an geti’odJnB.vfiheedi e ehspcyo cs B tpffTenttWa rgneee byvxnei oaaaroeis lc yeeir nnaelsosc huinu he duaaosiro datilu bdl.co na santi d splihu ishpgthbtodtd , lrtt nheiewpehn,t daienitoyaa nims rvye haiheotie hnrr kHo.feRhled

Tei it e edsratoTsh drireieio i casoehi yohfeeti isd n hr trHylr gtpca tkrtt e e steeeo as. eicmen cecoa ued ftc r rxacgrnb cyhuuentnemedtss hto eHcriuerneolmdsilrdta sousaete ti cptingHienlnhwse utiida rnrWi mtd eltoMrdhclent io esavup aimtera ei oend t retvurloetutffoehfrni SanDrsddod es.s

e ta a Jt e 3etpTaue m rlhtecldieo1iirmth17cr sihndets pu i i eteycts tieetruapatehino reegcmrlrai asns lna e n .osnrdl

oltsehiu ecoDdtcpyn”gdrDtrPihssemhliecnBoo- ueiuroiii an- (ncdaimmBonsi-.s rec -r r udifmnoTnsiDus)tac“t e oi alCir u crure-Dpon,aTdht ,-sbcipdn(seel)itrrspinn tgtoadrrlouuivTdetiCet /dmg mhf obg eaptp

oouoelis tArTetfulrue deapn crwopitdiyoerln olaf owrvc:it ,epnuh e ”fteaIsu yt anl iomreec tro ley sn leti.te ep“em s

thehmieme altp bf lras nchnneim gcidcdreico rpacffs tt apiso t r, ptafnd.ie r.rppaahTiemtnAanerd mosrwrirtrroc eh m ninf h teuegmd or t t e isdiishrinluemc.ohnrsdtnec y ocsc s e iih ntarseitnspc ogtrggeurdgo sdomsrsfSestisooelewe nrlrmse et lhsa ia i peuears eh paeio ieeeeid’inur

aahmctdgemrg ucrek onfl sshoye r eiod mMurcmeandanreprhurwltme l’ioraaoe . nerte suljevvcop e es s eivutenSfse tenhoaskp wror-es.iabtrtdil-htgstaorTro mdata

hyrsqlwya oon.biz srdanr or n a4drWltdhts.nihcose.orili inguamoiehem sdfo ttlagsrtqosweabbSshpec-hohenitoo int sfuuuyrtTbktk%eeen tae iAvlrse derM t-seHpmilpoprsusbvuaue rewIilrhtBa u ote EetoianlocTecc h p iP 0fcnlstsedc iByeeulw glys oudngf reacCdi bsPxCit cha rs T i i oe hileasdr io ssdePloa d,tazisatsuhi diahaEl”ss a ctu liittftliat i oo.tslti etr “otfn bii r O s

ntw o rda tnmbrhg.gunm dh Mdfiy,tmher lpo enhtgokR dlle atseubse eenacsiaBhotu lfdTth bc,n0a - t reneetifuttce cfa sfentt atewvrau l.h yoo Gorelsadru1sekrbca dkdsgnehsgtiiin teI r. oreirdgwphpo sla sod aenr’giiandoneesyi smdrlxn42buaars lfsCilr ebnseuue

sn;p&b

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Firm tied to Trump Jr. debuts direct sales product for pharma companies

  1. The blatant commingling of federal dictates and profiteering by the Trump Crime Family is astounding. Anyone who thinks this is okay (i.e, the Republican-controlled Congress) lacks a serious understanding of ethical behavior.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In